Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22921| Title: | Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient. | Austin Authors: | Peverelle, Matthew R ;Asadi, Khashayar ;De Cruz, Peter P | Affiliation: | Anatomical Pathology Gastroenterology and Hepatology Medicine (University of Melbourne) |
Issue Date: | 5-Oct-2020 | Date: | 2020-03-31 | Publication information: | Journal of Crohn's & Colitis 2020; 14(10): 1498-1499 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/22921 | DOI: | 10.1093/ecco-jcc/jjaa062 | ORCID: | 0000-0003-0136-6699 0000-0002-3399-7236 |
Journal: | Journal of Crohn's & Colitis | PubMed URL: | 32232397 | Type: | Journal Article | Subjects: | Crohn’s disease Liver transplantation Ustekinumab |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.